Therapy of advanced squamous carcinoma of the lung.Cyclophosphamide versus “COMB”
- 1 March 1977
- Vol. 39 (3), 1026-1031
- https://doi.org/10.1002/1097-0142(197703)39:3<1026::aid-cncr2820390305>3.0.co;2-p
Abstract
The four-drug combination of cyclophosphamide, vincristine, methyl CCNU and bleomycin was compared to CTX alone in a prospective randomized trial. Only one of 20 patients treated with COMB and one of 27 patients treated with CTX achieved a partial response. CTX was associated with a significantly better survival than COMB among patients who were ambulatory at onset of therapy. Survival among non-ambulatory patients was similar with both regimens.This publication has 8 references indexed in Scilit:
- A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's diseaseCancer, 1975
- Clinical comparison of the nitrosoureasCancer, 1975
- COMB (cyclophosphamide, oncovin, methyl-ccnu, and bleomycin): A four-drug combination in solid tumorsCancer, 1975
- Chemotherapy of Acute LeukemiaArchives of Internal Medicine, 1974
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Lung Cancer: Perspectives and ProspectsAnnals of Internal Medicine, 1970
- STATHMOKINETIC EFFECT OF VINCRISTINE1964
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960